Dr Reddys Laboratories LTD (RDY) — SEC Filings

Q: What are the key financial highlights for Dr Reddys Laboratories LTD?

Key financial highlights for Dr Reddys Laboratories LTD are extracted from the most recent 10-K or 10-Q filings, including revenue, net income, EPS, debt-to-equity, cash position, and operating margin.

Q: What is the investment thesis for RDY?

The investment thesis for RDY includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings filed by Dr Reddys Laboratories LTD.

Q: Who are the key executives at Dr Reddys Laboratories LTD?

Key executives at Dr Reddys Laboratories LTD are identified from SEC filings including 10-K annual reports, proxy statements, and insider trade forms.

Q: What are the main risk factors for Dr Reddys Laboratories LTD stock?

Risk factors for Dr Reddys Laboratories LTD (RDY) are assessed from SEC filings using AI analysis. Each filing is categorized as high, medium, or low risk based on disclosed risk factors and financial indicators.

Q: What are recent predictions and forward guidance from Dr Reddys Laboratories LTD?

Forward-looking statements and predictions from Dr Reddys Laboratories LTD are extracted from SEC filings including earnings reports, annual reports, and current event filings.

Latest SEC filings for Dr Reddys Laboratories LTD. Recent 6-K filing on Apr 24, 2026. AI-decoded analysis of earnings, risk factors, and insider trades.

View Dr Reddys Laboratories LTD on SEC EDGAR

Overview

Dr Reddys Laboratories LTD (RDY) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 6-K filed on Apr 24, 2026: On April 24, 2026, Dr. Reddy's Laboratories Ltd. filed a Form 6-K with the SEC. This report is a notification from a foreign issuer and does not contain specific financial details or material events beyond the filing itself. The filing includes the form 6-K document and associated exhibits.

Sentiment Summary

Across 50 filings, the sentiment breakdown is: 50 neutral. The dominant filing sentiment for Dr Reddys Laboratories LTD is neutral.

Filing Type Overview

Dr Reddys Laboratories LTD (RDY) has filed 50 6-K with the SEC between Jul 2025 to Apr 2026.

Filings by Year

2026 · 2025

Recent Filings (50)

6-K Filing — 6-K · Apr 24, 2026
Dr. Reddy's Laboratories Files Form 6-K — 6-K · Apr 24, 2026 Risk: low
On April 24, 2026, Dr. Reddy's Laboratories Ltd. filed a Form 6-K with the SEC. This report is a notification from a foreign issuer and does not contain specifi
6-K Filing — 6-K · Apr 15, 2026
Dr. Reddy's Laboratories Files 6-K Report — 6-K · Apr 8, 2026 Risk: low
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on April 8, 2026, reporting information as of April 7, 2026. The filing includes standard report documents and ex
DR REDDY'S Files Routine 6-K on March 26, 2026 — 6-K · Mar 26, 2026
DR REDDY'S LABORATORIES LTD filed a 6-K on March 26, 2026, indicating a routine report for foreign issuers. This filing, with accession number 0001575872-26-000
DR REDDYS LABS Files Routine 6-K, No Major News — 6-K · Mar 24, 2026
DR REDDYS LABORATORIES LTD filed a 6-K on March 24, 2026, which is a routine report for foreign issuers. This specific filing, with accession number 0001575872-
Dr. Reddy's Labs Files 6-K — 6-K · Dec 31, 2025 Risk: low
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on December 31, 2025, reporting its status as a foreign private issuer. The company, headquartered in Hyderabad,
Dr. Reddy's Labs Files 6-K Report — 6-K · Dec 23, 2025 Risk: low
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on December 23, 2025, reporting as a foreign private issuer. The company, based in Hyderabad, India, is a pharmac
6-K Filing — 6-K · Dec 16, 2025
Dr. Reddy's Labs Files 6-K, Confirms 20-F Reporting — 6-K · Dec 12, 2025 Risk: low
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on December 12, 2025, reporting as a foreign private issuer. The filing confirms that the company files annual re
6-K Filing — 6-K · Dec 10, 2025
Dr. Reddy's Labs Files 6-K Report — 6-K · Dec 8, 2025 Risk: low
Dr. Reddy's Laboratories Limited filed a Form 6-K on December 8, 2025, indicating it is a foreign private issuer submitting its report under Rule 13a-16 or 15d-
6-K Filing — 6-K · Dec 3, 2025
Dr. Reddy's Labs Files Routine 6-K — 6-K · Nov 28, 2025 Risk: low
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on November 28, 2025, reporting as a foreign private issuer. The company, based in Hyderabad, India, is a pharmac
Dr. Reddy's Laboratories Files Routine 6-K — 6-K · Nov 25, 2025 Risk: low
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on November 25, 2025, reporting as a foreign private issuer. The company, based in Hyderabad, India, is a pharmac
Dr. Reddy's Labs Files 6-K — 6-K · Nov 18, 2025 Risk: low
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on November 18, 2025, reporting as a foreign private issuer. The company is based in Hyderabad, India, and its pr
6-K Filing — 6-K · Nov 17, 2025
Dr. Reddy's Labs Files 6-K — 6-K · Nov 13, 2025 Risk: low
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on November 13, 2025, reporting as a foreign private issuer. The company, based in Hyderabad, India, is a pharmac
6-K Filing — 6-K · Nov 12, 2025
Dr. Reddy's Laboratories Files 6-K Report — 6-K · Oct 31, 2025 Risk: low
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on October 31, 2025, reporting for the period ending October 24, 2025. The company, based in Hyderabad, India, is
Dr. Reddy's Labs Files 6-K — 6-K · Oct 29, 2025 Risk: low
Dr. Reddy's Laboratories Limited filed a Form 6-K on October 29, 2025, reporting as a foreign private issuer. The company, based in Hyderabad, India, is a pharm
Dr. Reddy's Labs Files Routine 6-K — 6-K · Oct 27, 2025 Risk: low
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on October 27, 2025, reporting as a foreign private issuer. The company, based in Hyderabad, India, is a pharmace
Dr. Reddy's Labs Files Q3 2025 6-K Report — 6-K · Oct 24, 2025 Risk: low
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on October 24, 2025, reporting for the quarter ended September 30, 2025. The company, based in Hyderabad, India,
Dr. Reddy's Labs Files 6-K — 6-K · Oct 21, 2025 Risk: low
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on October 21, 2025, to report its status as a foreign private issuer. The company, headquartered in Hyderabad, I
Dr. Reddy's Labs Files 6-K, Confirms 20-F Reporting — 6-K · Oct 14, 2025 Risk: low
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on October 14, 2025, reporting as a foreign private issuer. The filing indicates the company is submitting its an
Dr. Reddy's Laboratories Files Routine 6-K Report — 6-K · Sep 22, 2025 Risk: low
Dr. Reddy's Laboratories Limited, based in Hyderabad, India, filed a Form 6-K on September 22, 2025. This report is a routine filing for a foreign private issue
Dr. Reddy's Labs Files 6-K Report — 6-K · Sep 19, 2025 Risk: low
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on September 19, 2025, reporting as a foreign private issuer. The filing indicates the company will file annual r
Dr. Reddy's Labs Files 6-K Report — 6-K · Sep 16, 2025 Risk: low
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on September 16, 2025, reporting as a foreign private issuer. The company, based in Hyderabad, India, is a pharma
Dr. Reddy's Files 6-K Report — 6-K · Sep 15, 2025 Risk: low
Dr. Reddy's Laboratories Limited filed a Form 6-K on September 15, 2025, confirming it files annual reports under Form 20-F. The filing is a report of a foreign
Dr. Reddy's Labs Files Routine 6-K — 6-K · Sep 11, 2025 Risk: low
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on September 11, 2025, reporting its status as a foreign private issuer. The company, headquartered in Hyderabad,
Dr. Reddy's Labs Files Routine 6-K Disclosure — 6-K · Sep 8, 2025 Risk: low
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on September 8, 2025, to report its status as a foreign private issuer. The company, headquartered in Hyderabad,
Dr. Reddy's Labs Files 6-K Report — 6-K · Sep 4, 2025 Risk: low
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on September 4, 2025, to report its status as a foreign private issuer. The company, headquartered in Hyderabad,
Dr. Reddy's Labs Files 6-K — 6-K · Sep 2, 2025 Risk: low
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on September 2, 2025, reporting as a foreign private issuer. The company, based in Hyderabad, India, is a pharmac
Dr. Reddy's Labs Files Routine 6-K Disclosure — 6-K · Sep 2, 2025 Risk: low
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on September 2, 2025, to report its status as a foreign private issuer. The company, headquartered in Hyderabad,
Dr. Reddy's Labs Files 6-K, Reports Under Form 20-F — 6-K · Aug 29, 2025 Risk: low
Dr. Reddy's Laboratories Limited filed a Form 6-K on August 29, 2025, reporting as a foreign private issuer. The filing indicates the company is submitting its
Dr. Reddy's Laboratories Files Routine 6-K — 6-K · Aug 26, 2025 Risk: low
Dr. Reddy's Laboratories Limited filed a Form 6-K on August 26, 2025, reporting as a foreign private issuer. The company, based in Hyderabad, India, is a pharma
Dr. Reddy's Labs Files 6-K, Confirms 20-F Reporting — 6-K · Aug 21, 2025 Risk: low
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on August 21, 2025, reporting as a foreign private issuer. The filing indicates the company is submitting its ann
Dr. Reddy's Labs Files 6-K with Updated Info — 6-K · Aug 13, 2025 Risk: low
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on August 13, 2025, confirming its status as a foreign private issuer filing annual reports under Form 20-F. The
Dr. Reddy's Labs Files 6-K with SEC — 6-K · Aug 11, 2025 Risk: low
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on August 11, 2025, indicating it is a foreign private issuer submitting its annual reports under Form 20-F. The
Dr. Reddy's Labs Files 6-K Report — 6-K · Aug 8, 2025 Risk: low
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on August 8, 2025, indicating it files annual reports under Form 20-F. The filing is a report of a foreign privat
Dr. Reddy's Labs Files 6-K, Confirms 20-F Reporting — 6-K · Jul 30, 2025 Risk: low
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on July 30, 2025, confirming it files annual reports under Form 20-F. The filing originates from Hyderabad, India
Dr. Reddy's Labs Files 6-K Report — 6-K · Jul 28, 2025 Risk: low
Dr. Reddy's Laboratories Limited filed a Form 6-K on July 28, 2025, reporting information as of July 25, 2025. The company, a foreign private issuer, is based i
Dr. Reddy's Laboratories Files Routine 6-K Report — 6-K · Jul 25, 2025 Risk: low
Dr. Reddy's Laboratories Limited filed a Form 6-K on July 25, 2025, confirming it files annual reports under Form 20-F. The filing is a routine report for a for
Dr. Reddy's Laboratories Files 6-K — 6-K · Jul 24, 2025 Risk: low
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on July 24, 2025, reporting as a foreign private issuer. The company, based in Hyderabad, India, is a pharmaceuti
Dr. Reddy's Laboratories Files 6-K Report — 6-K · Jul 23, 2025 Risk: low
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on July 23, 2025, to report its status as a foreign private issuer. The company, headquartered in Hyderabad, Indi
Dr. Reddy's Laboratories Files Routine 6-K — 6-K · Jul 22, 2025 Risk: low
Dr. Reddy's Laboratories Limited, based in Hyderabad, India, filed a Form 6-K on July 22, 2025. This report is a routine filing for a foreign private issuer and
Dr. Reddy's Laboratories Files Routine 6-K — 6-K · Jul 21, 2025 Risk: low
Dr. Reddy's Laboratories Limited, a pharmaceutical company based in India, filed a Form 6-K on July 21, 2025. This report is a routine filing for foreign privat
Dr. Reddy's Laboratories Files Routine 6-K Disclosure — 6-K · Jul 18, 2025 Risk: low
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on July 18, 2025, to report its status as a foreign private issuer. The company, headquartered in Hyderabad, Indi
Dr. Reddy's Labs Files 6-K Report — 6-K · Jul 15, 2025 Risk: low
Dr. Reddy's Laboratories Limited filed a Form 6-K on July 15, 2025, reporting as a foreign private issuer. The company, based in Hyderabad, India, is a pharmace
Dr. Reddy's Laboratories Files Routine 6-K Disclosure — 6-K · Jul 2, 2025 Risk: low
Dr. Reddy's Laboratories Limited filed a Form 6-K on July 2, 2025, to report its status as a foreign private issuer. The company, based in Hyderabad, India, is

Risk Profile

Risk Assessment: Of RDY's 41 recent filings, 0 were flagged as high-risk, 0 as medium-risk, and 41 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Top Tags

foreign-private-issuer (31) · sec-filing (27) · reporting (15) · foreign-issuer (8) · regulatory-filing (6) · compliance (6) · 6-K (5) · 6-k (5) · disclosure (3) · routine-filing (2)

Frequently Asked Questions

What are the latest SEC filings for Dr Reddys Laboratories LTD (RDY)?

Dr Reddys Laboratories LTD has 50 recent SEC filings from Jul 2025 to Apr 2026, including 50 6-K. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of RDY filings?

Across 50 filings, the sentiment breakdown is: 50 neutral. The dominant sentiment is neutral.

Where can I find Dr Reddys Laboratories LTD SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Dr Reddys Laboratories LTD (RDY) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Dr Reddys Laboratories LTD?

Financial highlights for Dr Reddys Laboratories LTD are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.

What is the investment thesis for RDY?

Investment thesis data for RDY will be available once enriched filings are processed.

Who are the key executives at Dr Reddys Laboratories LTD?

Executive information for Dr Reddys Laboratories LTD is extracted from SEC filings as they are enriched with AI analysis.

What are the main risk factors for Dr Reddys Laboratories LTD stock?

Of RDY's 41 assessed filings, 0 were flagged high-risk, 0 medium-risk, and 41 low-risk.

What are recent predictions and forward guidance from Dr Reddys Laboratories LTD?

Forward guidance and predictions for Dr Reddys Laboratories LTD are extracted from SEC filings as they are enriched.